US6861571B1
(en)
*
|
1994-11-28 |
2005-03-01 |
The Procter & Gamble Company |
Article having a lotioned topsheet
|
JPH10510540A
(ja)
|
1994-12-12 |
1998-10-13 |
オメロス メディカル システムズ,インコーポレーテッド |
灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
|
US6413961B1
(en)
|
1995-12-12 |
2002-07-02 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain and inflammation
|
US6916487B2
(en)
*
|
1996-02-19 |
2005-07-12 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiemetics
|
US6923983B2
(en)
*
|
1996-02-19 |
2005-08-02 |
Acrux Dds Pty Ltd |
Transdermal delivery of hormones
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
US6929801B2
(en)
*
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
US6916486B2
(en)
*
|
1996-02-19 |
2005-07-12 |
Acrux Dds Pty Ltd |
Transdermal delivery of analgesics
|
US6512010B1
(en)
*
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
GR1002847B
(el)
|
1997-05-06 |
1998-01-27 |
|
Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
|
US6767902B2
(en)
*
|
1997-09-17 |
2004-07-27 |
The Population Council, Inc. |
Androgen as a male contraceptive and non-contraceptive androgen replacement
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
EP1029536B1
(de)
*
|
1997-10-01 |
2007-11-28 |
Novadel Pharma Inc. |
Nichtpolare Spray zur bukkalen Verabreichung
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
US20030185761A1
(en)
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US7632517B2
(en)
*
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US5968919A
(en)
*
|
1997-10-16 |
1999-10-19 |
Macrochem Corporation |
Hormone replacement therapy drug formulations for topical application to the skin
|
US7098206B2
(en)
|
1998-01-21 |
2006-08-29 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
US6998400B2
(en)
|
1998-01-22 |
2006-02-14 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
CA2318738A1
(en)
*
|
1998-01-29 |
1999-08-05 |
Sepracor Inc. |
Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
|
JP2002501891A
(ja)
|
1998-01-29 |
2002-01-22 |
セプラコア インコーポレーテッド |
光学的に純粋な(+)−ビュープロピオンの医薬用途
|
AU2483599A
(en)
|
1998-01-29 |
1999-08-16 |
Sepracor, Inc. |
Pharmaceutical uses of optically pure (-)-bupropion
|
DE19814084B4
(de)
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
IL124764A0
(en)
*
|
1998-06-04 |
1999-01-26 |
Univ Ben Gurion |
Topical composition for treatment of baldness
|
DE19825591A1
(de)
*
|
1998-06-09 |
1999-12-23 |
Jenapharm Gmbh |
Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
|
GR1003199B
(el)
|
1998-08-14 |
1999-09-01 |
|
Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες
|
DE69933775T2
(de)
|
1998-08-20 |
2007-10-04 |
3M Innovative Properties Co., St. Paul |
Sprühverband und wirkstoffabgabesystem
|
ATE295159T1
(de)
*
|
1998-12-08 |
2005-05-15 |
Planisphere Corp |
Bupropion zur behandlung von viralen erkrankungen
|
GB9828480D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Dermatech Limited |
Transdermal drug delivery system
|
CA2370003C
(en)
|
1999-01-13 |
2008-08-19 |
Tracey Brown |
A composition and method for the enhancement of the efficacy of drugs
|
US6734213B2
(en)
|
1999-01-20 |
2004-05-11 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
US6855820B2
(en)
|
1999-01-20 |
2005-02-15 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
KR100390870B1
(ko)
*
|
1999-02-09 |
2003-07-10 |
주식회사 삼양사 |
경피투여용 항구토제 조성물 및 이를 포함하는 제제
|
US6337328B1
(en)
|
1999-03-01 |
2002-01-08 |
Sepracor, Inc. |
Bupropion metabolites and methods of use
|
US6342496B1
(en)
|
1999-03-01 |
2002-01-29 |
Sepracor Inc. |
Bupropion metabolites and methods of use
|
NZ513825A
(en)
|
1999-03-05 |
2001-09-28 |
Procter & Gamble |
C 16 unsaturated FP-selective prostaglandins analogs
|
DE19918105C1
(de)
|
1999-04-22 |
2000-09-21 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
|
EP1175204A4
(de)
*
|
1999-05-04 |
2006-05-31 |
Aradigm Corp |
Aerosolformulierung und artikel zur steigerung der libido bei frauen durch momentane testosteronverabreichung
|
US6632419B2
(en)
|
1999-05-04 |
2003-10-14 |
Aradigm Corporation |
Increasing libido in humans via acute testosterone administration
|
US6428769B1
(en)
*
|
1999-05-04 |
2002-08-06 |
Aradigm Corporation |
Acute testosterone administration
|
US7258850B2
(en)
|
1999-05-04 |
2007-08-21 |
Aradigm Corporation |
Methods and compositions for treating erectile dysfunction
|
US6312716B1
(en)
*
|
1999-05-10 |
2001-11-06 |
Peierce Management Llc |
Patch and method for transdermal delivery of bupropion base
|
US6280763B1
(en)
|
1999-05-10 |
2001-08-28 |
Pierce Management, Llc |
Apparatus and method for transdermal delivery of bupropion
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
US6595947B1
(en)
*
|
2000-05-22 |
2003-07-22 |
Becton, Dickinson And Company |
Topical delivery of vaccines
|
US7241731B2
(en)
|
2000-06-05 |
2007-07-10 |
Sumitomo Electric Industries, Ltd. |
Oligopeptides for promoting hair growth
|
US20050008602A1
(en)
*
|
2000-06-05 |
2005-01-13 |
Sumitomo Electric Industries, Ltd. |
Oligopeptides for promoting hair growth
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
AUPQ879500A0
(en)
*
|
2000-07-14 |
2000-08-10 |
Meditech Research Limited |
Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
|
US9066919B2
(en)
*
|
2000-07-14 |
2015-06-30 |
Alchemia Oncology Pty Limited |
Hyaluronan as a chemo-sensitizer in the treatment of cancer
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
AU8206401A
(en)
|
2000-08-03 |
2002-02-18 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
DE10041479A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
|
DE10041478A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
DE10043321B4
(de)
*
|
2000-08-24 |
2005-07-28 |
Neurobiotec Gmbh |
Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
|
DE10053397A1
(de)
|
2000-10-20 |
2002-05-02 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
DE10042411A1
(de)
*
|
2000-08-30 |
2002-03-28 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Abgabe von Exemestan
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
MXPA03001858A
(es)
*
|
2000-08-30 |
2004-05-21 |
Unimed Pharmaceuticals Inc |
Metodo para el tratamiento de la disfuncion erectil e incremento en el libido del hombre.
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
KR20030043955A
(ko)
*
|
2000-09-08 |
2003-06-02 |
파마시아 이탈리아 에스.피.에이. |
화학적 예방제로서 엑스메스탄
|
DE10064453A1
(de)
*
|
2000-12-16 |
2002-07-04 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
US20020177626A1
(en)
|
2001-01-19 |
2002-11-28 |
Cook Graham D. |
Treatment of sleep disturbances
|
FR2815256A1
(fr)
*
|
2001-01-23 |
2002-04-19 |
Oreal |
Composition, notamment cosmetique, comprenant au moins un derive de sapogenine et au moins un solubilisant du derive de sapogenine
|
JP3767392B2
(ja)
*
|
2001-02-05 |
2006-04-19 |
日産自動車株式会社 |
エンジンのカム軸回転位相検出装置及びシリンダ吸入空気量算出装置
|
US20020172732A1
(en)
*
|
2001-03-21 |
2002-11-21 |
Wies Ter Laak |
Composition comprising cocoa
|
US20030026830A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
US20030027793A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal treatment of parkinson's disease
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
EP1392262A1
(de)
|
2001-05-24 |
2004-03-03 |
Alexza Molecular Delivery Corporation |
Verabreichung von arzneimittel-estern durch inhalation
|
US7244703B2
(en)
|
2001-06-22 |
2007-07-17 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for peptide treatment
|
TWI331522B
(en)
*
|
2001-06-22 |
2010-10-11 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
WO2003018023A1
(en)
*
|
2001-08-23 |
2003-03-06 |
Bruce Frome |
Compositions and methods for targeting cerebral circulation and treatment of headache
|
US20040138239A1
(en)
*
|
2001-08-23 |
2004-07-15 |
Bruce Frome |
Compositions and methods for targeting cerebral circulation and treatment of headache
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
CA2458856C
(en)
*
|
2001-08-27 |
2011-02-15 |
Meditech Research Limited |
Improved therapeutic protocols
|
US6723077B2
(en)
|
2001-09-28 |
2004-04-20 |
Hewlett-Packard Development Company, L.P. |
Cutaneous administration system
|
AU2002365144A1
(en)
*
|
2001-10-29 |
2003-06-30 |
Becton, Dickinson And Company |
Method and device for the delivery of a substance
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
US7037513B1
(en)
|
2005-01-31 |
2006-05-02 |
Aquea Scientific Corporation |
Bodywash additives
|
US6998113B1
(en)
|
2005-01-31 |
2006-02-14 |
Aquea Scientific Corporation |
Bodywashes containing additives
|
US7025952B1
(en)
|
2005-01-31 |
2006-04-11 |
Aquea Scientific Corporation |
Methods of preparation and use of bodywashes containing additives
|
US20060173709A1
(en)
*
|
2005-01-31 |
2006-08-03 |
Traynor Daniel H |
Bodywash additive business methods
|
JP2005513080A
(ja)
|
2001-12-20 |
2005-05-12 |
フェムファーマ, インコーポレイテッド |
薬物の膣送達
|
US20040097871A1
(en)
*
|
2002-01-03 |
2004-05-20 |
Israel Yerushalmy |
Apparatus for treating sleep disorders
|
US20030143165A1
(en)
*
|
2002-01-25 |
2003-07-31 |
Allan Evans |
NSAID-containing topical formulations that demonstrate chemopreventive activity
|
US20030161802A1
(en)
*
|
2002-02-05 |
2003-08-28 |
Flammer Linda J. |
Anti-dandruff and anti-itch compositions containing sensate and sensate enhancer-containing compounds
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
AUPS317302A0
(en)
*
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Metastable pharmaceutical compositions
|
KR20100055542A
(ko)
*
|
2002-06-25 |
2010-05-26 |
애크럭스 디디에스 피티와이 리미티드 |
비정질 약학적 조성물을 이용한 경피전달속도의 제어
|
AUPS317102A0
(en)
*
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Transdermal aerosol compositions
|
JP2005535614A
(ja)
*
|
2002-06-25 |
2005-11-24 |
コズメシューティック ソリューションズ プロプライエタリー リミテッド |
局所用美容組成物
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
AU2003238543B2
(en)
*
|
2002-06-25 |
2008-02-28 |
Acrux Dds Pty Ltd |
Transdermal aerosol compositions
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
EP1386605A1
(de)
*
|
2002-07-30 |
2004-02-04 |
Schwarz Pharma Ag |
Verbessertes transdermales System für die Verabreichung von Rotigotin
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
DE10234673B4
(de)
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
CA2502986C
(en)
|
2002-10-25 |
2011-08-23 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US7192614B2
(en)
|
2002-11-05 |
2007-03-20 |
Gelstat Corporation |
Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
|
US20040086579A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Higgins James W. |
Dietary supplement comprising parthenolide
|
US7374772B2
(en)
*
|
2002-11-07 |
2008-05-20 |
Bommarito Alexander A |
Topical antifungal treatment
|
MXPA05005609A
(es)
*
|
2002-11-26 |
2005-07-26 |
Alexza Pharmaceuticals Inc |
Tratamiento de dolor de cabeza con antipsicoticos suministrados por inhalacion.
|
CN101371843B
(zh)
|
2002-11-26 |
2012-09-26 |
艾利斯达医药品公司 |
洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
|
US20040105818A1
(en)
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
ES2239196T3
(es)
*
|
2002-12-02 |
2005-09-16 |
Schwarz Pharma Ag |
Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson.
|
US20040220198A1
(en)
*
|
2002-12-20 |
2004-11-04 |
Kasturi Haldar |
Methods for treating malaria by modulation of G protein function
|
AU2004203700B2
(en)
*
|
2003-01-02 |
2007-06-21 |
Femmepharma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
US20040247707A1
(en)
*
|
2003-01-06 |
2004-12-09 |
Le Roy Charles Richard |
Pearl blue fast acting, long lasting topical pain relief cream
|
WO2004064841A1
(en)
|
2003-01-23 |
2004-08-05 |
Shire Holdings Ag |
Formulation and methods for the treatment of thrombocythemia
|
EP1444976A1
(de)
*
|
2003-02-10 |
2004-08-11 |
Novadel Pharma Inc. |
Bukkale, polare und nichtpolare Spray und Kapsel
|
ITFI20030070A1
(it)
*
|
2003-03-18 |
2004-09-19 |
Berlin Chemie Ag |
Formulazioni topiche stabilizzate contenenti ketoprofene
|
CA2522028C
(en)
|
2003-04-10 |
2011-11-01 |
Neurogesx, Inc. |
Methods and compositions for administration of trpv1 agonists
|
US7632531B2
(en)
*
|
2003-04-11 |
2009-12-15 |
International Flavors & Fragnances Inc. |
Alkyldienamides exhibiting taste and sensory effect in flavor compositions
|
US7361376B2
(en)
*
|
2003-04-11 |
2008-04-22 |
International Flavors & Fragrances Inc. |
Alkyldienamides exhibiting taste and sensory effect in flavor compositions
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
ATE510174T1
(de)
|
2003-05-21 |
2011-06-15 |
Alexza Pharmaceuticals Inc |
Schlag gezündete unabhängige heizeinheit
|
US20040247706A1
(en)
*
|
2003-06-06 |
2004-12-09 |
Roberts Stephen C. |
Transdermal dietary supplement comprising parthenolide
|
US20040247705A1
(en)
*
|
2003-06-06 |
2004-12-09 |
Roberts Stephen C. |
Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
|
US20040259852A1
(en)
*
|
2003-06-18 |
2004-12-23 |
White Hillary D. |
Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
|
US8883769B2
(en)
*
|
2003-06-18 |
2014-11-11 |
White Mountain Pharma, Inc. |
Methods for the treatment of fibromyalgia and chronic fatigue syndrome
|
EP1488787A1
(de)
*
|
2003-06-20 |
2004-12-22 |
Berlin-Chemie Ag |
Topisch anzuwendende stabilisierte Arzneimittel enthaltend Ketoprofen
|
CA2433101A1
(en)
*
|
2003-06-23 |
2004-12-23 |
Igor Gonda |
Method of treatment of a female suffering from androgen insufficiency
|
US20050037040A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of urea and ammonium lactate
|
US20050042182A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Moshe Arkin |
Topical compositions of urea
|
US20050036953A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of ammonium lactate
|
US6884906B2
(en)
*
|
2003-07-01 |
2005-04-26 |
International Flavors & Fragrances Inc. |
Menthyl half acid ester derivatives, processes for preparing same, and uses thereof for their cooling/refreshing effect in consumable materials
|
US7141686B2
(en)
*
|
2003-07-10 |
2006-11-28 |
International Flavors & Fragrances Inc. |
E2, E4, Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
|
US20050020552A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
US20050042268A1
(en)
*
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
US20050025833A1
(en)
*
|
2003-07-16 |
2005-02-03 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
US7323191B2
(en)
|
2003-07-28 |
2008-01-29 |
Alza Corporation |
Transdermal warfarin system
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
AU2004264974A1
(en)
*
|
2003-08-15 |
2005-02-24 |
Arius Two, Inc. |
Adhesive bioerodible transmucosal drug delivery system
|
US20060018852A1
(en)
*
|
2003-08-22 |
2006-01-26 |
L'oreal |
Compositions containing topical active agents and pentylene glycol
|
US20050043283A1
(en)
*
|
2003-08-22 |
2005-02-24 |
L'oreal S.A. |
Compositions containing topical active agents and pentylene glycol
|
US20060263350A1
(en)
*
|
2003-09-26 |
2006-11-23 |
Fairfield Clinical Trials Llc |
Combination antihistamine medication
|
US7329767B2
(en)
*
|
2003-10-03 |
2008-02-12 |
International Flavors & Fragrances Inc. |
Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
|
US8007839B2
(en)
*
|
2003-10-03 |
2011-08-30 |
International Flavors & Fragrances |
Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
|
US7387788B1
(en)
|
2003-10-10 |
2008-06-17 |
Antares Pharma Ipl Ag |
Pharmaceutical compositions of nicotine and methods of use thereof
|
PL1670433T3
(pl)
|
2003-10-10 |
2013-03-29 |
Ferring Bv |
Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
|
KR100552650B1
(ko)
*
|
2003-11-17 |
2006-02-20 |
아이큐어 주식회사 |
피록시캄 함유 소염진통용 플라스터
|
EP1541136A1
(de)
*
|
2003-12-10 |
2005-06-15 |
Schering AG |
UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten
|
BRPI0417437A
(pt)
*
|
2003-12-10 |
2007-03-06 |
Acrux Dds Pty Ltd |
dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose
|
US20050129756A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Hans-Peter Podhaisky |
UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient
|
EP1547592A1
(de)
|
2003-12-23 |
2005-06-29 |
Schwarz Pharma Ag |
Intranasale formulierung enthaltend
|
DE10361258A1
(de)
|
2003-12-24 |
2005-07-28 |
Schwarz Pharma Ag |
Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
|
DE102004014841B4
(de)
|
2004-03-24 |
2006-07-06 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US8907153B2
(en)
*
|
2004-06-07 |
2014-12-09 |
Nuvo Research Inc. |
Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
|
US8741332B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for dermally treating neuropathic pain
|
US8741333B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for treating dermatitis or psoriasis
|
WO2005123043A2
(en)
*
|
2004-06-10 |
2005-12-29 |
Duramed Pharmaceuticals, Inc. |
Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
|
US20060030574A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Shire Holdings Ag |
Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
|
US7700608B2
(en)
*
|
2004-08-04 |
2010-04-20 |
Shire Holdings Ag |
Quinazoline derivatives and their use in the treatment of thrombocythemia
|
US20070264319A1
(en)
*
|
2004-09-01 |
2007-11-15 |
Lebo David B |
Transdermal Antiemesis Delivery System, Method and Composition Therefor
|
US7427421B2
(en)
*
|
2004-09-10 |
2008-09-23 |
International Flavors & Fragrances Inc. |
Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
|
US7541055B2
(en)
*
|
2004-09-10 |
2009-06-02 |
International Flavors & Fragrances Inc. |
Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
|
PL1814531T3
(pl)
|
2004-10-21 |
2010-11-30 |
Durect Corp |
Transdermalne systemy dostarczania
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
US7001592B1
(en)
*
|
2005-01-31 |
2006-02-21 |
Aquea Scientific Corporation |
Sunscreen compositions and methods of use
|
WO2006084312A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Acrux Dds Pty Ltd |
Method of promoting hair growth
|
ZA200707492B
(en)
*
|
2005-02-14 |
2009-02-25 |
Neurogesx Inc |
Device for delivery of TRPV1 agonists
|
JP5577021B2
(ja)
|
2005-02-17 |
2014-08-20 |
アボット・ラボラトリーズ |
動物における障害を治療および予防するための薬剤組成物の経粘膜投与
|
US20080112904A1
(en)
*
|
2005-03-08 |
2008-05-15 |
Daniel Henry Traynor |
Sunscreen Compositions And Methods Of Use
|
EP2601964B1
(de)
*
|
2005-03-21 |
2018-07-25 |
The Trustees of Columbia University in the City of New York |
Balanol-verbindungen zur Anwendung bei der Behandlung von Schmerz
|
AU2006227561B2
(en)
*
|
2005-03-24 |
2011-06-09 |
Ensign Laboratories Pty Ltd |
Sunscreen aerosol spray
|
ES2632631T3
(es)
*
|
2005-03-24 |
2017-09-14 |
Ensign Laboratories Pty Ltd |
Pulverización en aerosol como protección solar
|
WO2006105481A1
(en)
*
|
2005-03-30 |
2006-10-05 |
Neurogesx, Inc. |
Low-concentration capsaicin patch and methods for treating neuropathic pain
|
US20060222692A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Fairfield Clinical Trials Llc |
Method and compositions for transdermal administration of antimicrobial medications
|
WO2006122345A1
(en)
*
|
2005-05-16 |
2006-11-23 |
Novapharm Research (Australia) Pty Ltd |
Method and composition for use in preparation of a patient for surgery
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
ZA200711040B
(en)
*
|
2005-06-03 |
2009-04-29 |
Acrux Dds Pty Ltd |
Method and composition for transdermal drug delivery
|
EP1896038B1
(de)
*
|
2005-06-03 |
2016-11-09 |
Acrux DDS Pty Ltd |
Verfahren und zusammensetzung für die transdermale abgabe von testosteron
|
JP4696701B2
(ja)
|
2005-06-07 |
2011-06-08 |
ソニー株式会社 |
抵抗回路
|
RU2408368C2
(ru)
*
|
2005-06-27 |
2011-01-10 |
Биовэйл Лэборэториз Интернэшнл С.Р.Л. |
Препараты соли бупропиона с модифицированным высвобождением
|
KR100699582B1
(ko)
|
2005-07-11 |
2007-03-23 |
삼성전기주식회사 |
출력 버퍼회로
|
CA2616607C
(en)
*
|
2005-07-27 |
2015-06-02 |
Alchemia Oncology Pty Limited |
Therapeutic protocols using hyaluronan
|
EP1909778B1
(de)
*
|
2005-07-28 |
2017-12-13 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Monophenol-, Benzendiol- and Sulfhydrylverbindungen zur Verwendung bei der Behandlung von Melanomen
|
JP5627181B2
(ja)
*
|
2005-09-07 |
2014-11-19 |
アルケミア オンコロジー ピーティーワイ リミテッド |
ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法
|
BRPI0617294B8
(pt)
|
2005-10-12 |
2021-05-25 |
Besins Healthcare Lu Sarl |
composição farmacêutica em gel hidroalcóolico e uso de testosterona
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
WO2007051243A1
(en)
*
|
2005-11-04 |
2007-05-10 |
Acrux Dds Pty Ltd |
Method and system for transdermal drug delivery
|
WO2007061828A2
(en)
*
|
2005-11-21 |
2007-05-31 |
Schering-Plough Ltd. |
Pharmaceutical compositions comprising buprenorphine
|
GB0524958D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Transdermal administration of active agents
|
GB0524961D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Transdermal administration of active agents for systemic effect
|
GB0524962D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Topical pharmaceutical compositions
|
EP1962795A1
(de)
*
|
2005-12-07 |
2008-09-03 |
PharmaKodex Ltd |
Topische zusammensetzungen zur anwendung bei kindern
|
CN101378729B
(zh)
*
|
2005-12-14 |
2013-09-11 |
扎尔斯制药公司 |
治疗皮肤症状的制剂和方法
|
JP2009524586A
(ja)
*
|
2005-12-14 |
2009-07-02 |
ザーズ, インコーポレイテッド |
疼痛を皮膚処置するための組成物および方法
|
US9017717B2
(en)
*
|
2006-01-16 |
2015-04-28 |
Peach Technologies Llc |
Bandage for facilitating transdermal respiration and healing
|
MX2008009652A
(es)
|
2006-01-24 |
2008-11-06 |
R Tech Ueno Ltd |
Composicion farmaceutica que comprende un compuesto biciclico y metodo para estabilizar el compuesto biciclico.
|
WO2007095586A2
(en)
|
2006-02-14 |
2007-08-23 |
The Trustees Of Columbia University In The City Of New York |
Neuronal pain pathway modulators
|
DE102006010329A1
(de)
*
|
2006-03-06 |
2007-09-13 |
Höltge, Michael, Dipl.-Med. |
Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
|
US20080044462A1
(en)
*
|
2006-04-06 |
2008-02-21 |
Collegium Pharmaceutical, Inc. Delaware |
Stabilized transdermal bupropion preparations
|
EP2015632B1
(de)
*
|
2006-04-19 |
2015-12-02 |
Mist Pharmaceuticals, LLC |
Stabile wässrig-alkoholische mundsprayformulierungen und verfahren
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
US9468600B2
(en)
|
2006-05-26 |
2016-10-18 |
Dr. Holmquist Healthcare, LLC |
Compositions for the transdermal delivery of physiologically active agents
|
TW200815045A
(en)
*
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
US20080090850A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Anderson Mark E |
Herpetic neuralgia topical treatment
|
DE102006050558B4
(de)
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
US8304420B2
(en)
|
2006-11-28 |
2012-11-06 |
Shire Llc |
Substituted quinazolines for reducing platelet count
|
US7910597B2
(en)
*
|
2006-11-28 |
2011-03-22 |
Shire Llc |
Substituted quinazolines
|
US20080171089A1
(en)
*
|
2006-12-22 |
2008-07-17 |
Blondino Frank E |
Stable anti-nausea oral spray formulations and methods
|
US8236852B2
(en)
*
|
2007-01-08 |
2012-08-07 |
Androscience Corporation |
Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
|
MX2009007366A
(es)
*
|
2007-01-11 |
2009-07-16 |
Acrux Dds Pty Ltd |
Implemento para untar.
|
JP5319121B2
(ja)
|
2007-01-30 |
2013-10-16 |
株式会社東芝 |
診療支援システム及び診療支援装置
|
ES2594867T3
(es)
|
2007-03-09 |
2016-12-23 |
Alexza Pharmaceuticals, Inc. |
Unidad de calentamiento para usar en un dispositivo de administración de fármaco
|
WO2008116004A2
(en)
|
2007-03-19 |
2008-09-25 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin b12
|
WO2008128280A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Acrux Dds Pty Ltd |
Method and system for transdermal administration of volatile active
|
CA2687085A1
(en)
*
|
2007-05-10 |
2008-11-20 |
Novadel Pharma Inc. |
Anti-insomnia compositions and methods
|
CA2688812A1
(en)
*
|
2007-05-21 |
2008-11-27 |
Aquea Scientific Corporation |
Highly charged microcapsules
|
DE102007032468A1
(de)
|
2007-07-10 |
2009-01-15 |
Brätter, Christian, Dr. |
Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
|
HU227970B1
(en)
*
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
AR068409A1
(es)
*
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
Composiciones farmaceuticas, transdermicas sin alcohol
|
AR068408A1
(es)
*
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
Pulverizacion de hormonas transdermicas
|
DK2219603T3
(da)
*
|
2007-11-02 |
2014-09-01 |
Acrux Dds Pty Ltd |
Transdermalt afgivelsessystem
|
US9439857B2
(en)
|
2007-11-30 |
2016-09-13 |
Foamix Pharmaceuticals Ltd. |
Foam containing benzoyl peroxide
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
AU2009205314A1
(en)
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
WO2009092040A2
(en)
*
|
2008-01-17 |
2009-07-23 |
Gary Dean Bennett |
Topical pain formulation
|
US8123082B2
(en)
*
|
2008-01-22 |
2012-02-28 |
McNeil-AB |
Hand-held dispensing device
|
EP2247277A2
(de)
*
|
2008-01-25 |
2010-11-10 |
B & T S.r.l. |
Verwendung von transverestertem olivenöl in der kosmetik
|
JP4879928B2
(ja)
*
|
2008-03-25 |
2012-02-22 |
帝國製薬株式会社 |
ケトプロフェンリジン塩を含有する水性貼付剤
|
US20090259176A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Los Gatos Research, Inc. |
Transdermal patch system
|
US20110097393A1
(en)
*
|
2008-06-25 |
2011-04-28 |
US WorldMeade, LLC |
Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery
|
US20100048598A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Sateesh Kandavilli |
Topical compositions comprising 5-alpha reductase inhibitors
|
CA2737461A1
(en)
|
2008-09-19 |
2010-03-25 |
Tandem Diabetes Care, Inc. |
Solute concentration measurement device and related methods
|
US8748177B2
(en)
*
|
2008-09-30 |
2014-06-10 |
The Hospital For Sick Children |
Compositions for proliferation of cells and related methods
|
NZ591834A
(en)
|
2008-10-02 |
2011-12-22 |
Mylan Inc |
Method of making a multilayer adhesive laminate
|
CN102307895A
(zh)
*
|
2008-12-04 |
2012-01-04 |
里兰斯坦福初级大学理事会 |
用于治疗或预防麻醉药停药症状的方法和组合物
|
EP2401587A2
(de)
|
2009-02-27 |
2012-01-04 |
Tandem Diabetes Care, Inc. |
Verfahren und vorrichtungen zur bestimmung des flussreservoirvolumens
|
US9250106B2
(en)
|
2009-02-27 |
2016-02-02 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
US20100298397A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Singh Nikhilesh N |
Method of treatment of obsessive compulsive disorder with ondansetron
|
US9517023B2
(en)
*
|
2009-06-01 |
2016-12-13 |
Profusa, Inc. |
Method and system for directing a localized biological response to an implant
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
EP3284494A1
(de)
|
2009-07-30 |
2018-02-21 |
Tandem Diabetes Care, Inc. |
Tragbares infusionspumpensystem
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
WO2011039637A2
(en)
|
2009-10-02 |
2011-04-07 |
Foamix Ltd. |
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
WO2011044540A1
(en)
|
2009-10-09 |
2011-04-14 |
Nuvo Research Inc. |
Topical formulation comprising etoricoxib and a zwitterionic surfactant
|
US8439896B2
(en)
*
|
2009-11-13 |
2013-05-14 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
US8894630B2
(en)
|
2009-11-13 |
2014-11-25 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
US9078863B2
(en)
*
|
2009-11-13 |
2015-07-14 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
WO2011130455A1
(en)
|
2010-04-13 |
2011-10-20 |
Najib Babul |
Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
|
NZ602978A
(en)
|
2010-05-04 |
2014-10-31 |
Nexmed Holdings Inc |
Compositions of small molecule therapeutics
|
US10010272B2
(en)
|
2010-05-27 |
2018-07-03 |
Profusa, Inc. |
Tissue-integrating electronic apparatus
|
US20120022033A1
(en)
*
|
2010-07-23 |
2012-01-26 |
Biosante Pharmaceuticals, Inc. |
Methods for decreasing cardiovascular risk in postmenopausal women
|
WO2012037193A2
(en)
|
2010-09-17 |
2012-03-22 |
Brassica Protection Products Llc |
Formulations for treatment with glucosinolate
|
CN103260501B
(zh)
|
2010-10-06 |
2015-09-02 |
普罗弗萨股份有限公司 |
组织整合性传感器
|
EP2606895A4
(de)
*
|
2010-10-12 |
2014-04-02 |
Univ Wuhan |
Pflaster zur transdermalen absorption eines antivirus-wirkstoffs und verfahren zu seiner herstellung
|
SE535588C2
(sv)
*
|
2010-10-29 |
2012-10-02 |
Redsense Medical Ab |
Detektion av blodläckage genom påvisning av förekomsten av flyktiga ämnen
|
JP6912852B2
(ja)
|
2010-11-18 |
2021-08-04 |
ホワイト マウンテン ファーマ,インコーポレイテッド |
対象における慢性または解決不能な疼痛を処置するための、および/または痛覚閾値を高めるための方法、およびこれに用いる医薬組成物
|
HUE041353T2
(hu)
|
2011-02-15 |
2019-05-28 |
Elanco Us Inc |
Eljárás fájdalom csillapítására kutyafélékben fentanil transzdermális oldatának alkalmazásával
|
CA2827488C
(en)
|
2011-02-15 |
2020-07-07 |
Amy Louise Marr |
Methods for controlling pain in equines using a transdermal solution of fentanyl
|
US9119793B1
(en)
|
2011-06-28 |
2015-09-01 |
Medicis Pharmaceutical Corporation |
Gastroretentive dosage forms for doxycycline
|
WO2013032535A1
(en)
*
|
2011-08-26 |
2013-03-07 |
O'neil Michael P |
Tattoo removal system and method
|
PT2782584T
(pt)
|
2011-11-23 |
2021-09-02 |
Therapeuticsmd Inc |
Preparações e terapias de substituição para hormonoterapias naturais combinadas
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CN103181956B
(zh)
*
|
2011-12-30 |
2015-04-29 |
天津市山佳医药科技有限公司 |
一种治疗退行性骨关节痛的透皮吸收贴剂
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10045965B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
US11154535B2
(en)
|
2012-07-31 |
2021-10-26 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
US10045935B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
BR112015006176B1
(pt)
|
2012-09-21 |
2023-04-18 |
Intensity Therapeutics, Inc |
Uso de um agente terapêutico e de um agente de intensificação de permeação intracelular
|
EP2908853B1
(de)
|
2012-10-21 |
2018-12-05 |
University Of Rochester |
Thy1 (cd90) als therapie zur steuerung von fettgewebeakkumulation
|
US10322301B2
(en)
|
2012-11-06 |
2019-06-18 |
CoLabs International Corporation |
Compositions containing a cellulose derived capsule with a sunscreen active agent
|
US11707421B2
(en)
|
2012-11-06 |
2023-07-25 |
Colabs Int'l Corp. |
Compositions containing a flexible derived capsule with an active agent
|
US11724134B2
(en)
|
2012-11-06 |
2023-08-15 |
CoLabs International Corporation |
Compositions containing a cellulose derived capsule with a sunscreen active agent
|
US11690793B2
(en)
|
2012-11-06 |
2023-07-04 |
Colabs Int'l Corp. |
Composition containing a cellulose derived capsule with a sunscreen
|
US11491088B2
(en)
|
2012-11-06 |
2022-11-08 |
CoLabs International Corporation |
Compositions containing a capsule with a moisturizing agent
|
EP2916814B1
(de)
|
2012-11-06 |
2020-02-12 |
Colabs International Corporation |
Zusammensetzung mit einer aus cellulose abgeleiteten kapsel mit einem sonnenschutzmittel
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
CA2939259C
(en)
|
2013-02-11 |
2021-01-26 |
Glycanova As |
Basidiomycete-derived cream for treatment of skin diseases
|
CA2904031A1
(en)
|
2013-03-14 |
2014-10-02 |
Profusa, Inc. |
Method and device for correcting optical signals
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
US10842802B2
(en)
|
2013-03-15 |
2020-11-24 |
Medicis Pharmaceutical Corporation |
Controlled release pharmaceutical dosage forms
|
CN111544011B
(zh)
|
2013-06-06 |
2023-06-06 |
普罗菲尤萨股份有限公司 |
用于探测来自植入传感器的光信号的设备和方法
|
USD749225S1
(en)
|
2013-11-26 |
2016-02-09 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
USD750788S1
(en)
|
2013-11-26 |
2016-03-01 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
USD752287S1
(en)
|
2013-12-09 |
2016-03-22 |
Amneal Pharmaceuticals Llc |
Applicator for applying a liquid to a surface
|
US9227044B2
(en)
|
2013-12-09 |
2016-01-05 |
Amneal Pharmaceuticals Llc |
Applicator for applying a fluid to a surface
|
KR101934169B1
(ko)
*
|
2013-12-24 |
2018-12-31 |
더 프록터 앤드 갬블 캄파니 |
피부 케어 활성제의 증진된 침투를 제공하는 화장 조성물 및 방법
|
US9561233B2
(en)
|
2014-03-13 |
2017-02-07 |
Demerx, Inc. |
Use of ibogaine for the treatment of pain
|
KR102364378B1
(ko)
|
2014-05-21 |
2022-02-16 |
에스케이케미칼 주식회사 |
안정성을 향상시킨 로티고틴 함유 경피흡수제제
|
JP2017516768A
(ja)
|
2014-05-22 |
2017-06-22 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
天然の併用ホルモン補充療法剤及び療法
|
US11696883B2
(en)
|
2014-05-23 |
2023-07-11 |
Triple Hair Inc. |
Compositions for reducing hair loss and/or increasing hair regrowth
|
ES2754353T3
(es)
|
2014-05-23 |
2020-04-17 |
Triple Hair Inc |
Composiciones para reducir la caída del cabello y/o aumentar la regeneración del cabello
|
US20160022643A1
(en)
*
|
2014-07-22 |
2016-01-28 |
Professional Compounding Centers Of America |
Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
|
US9592239B2
(en)
|
2014-09-12 |
2017-03-14 |
Demerx, Inc. |
Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
薬剤送達方法及びシステム
|
TW201705962A
(zh)
|
2015-03-23 |
2017-02-16 |
生物製藥X公司 |
皮膚用四環素醫藥組成物
|
US20160307158A1
(en)
*
|
2015-04-16 |
2016-10-20 |
Linkedin Corporation |
Aggregating and transforming user actions into social signal features for a job recommendation engine
|
ES2902842T3
(es)
|
2015-07-08 |
2022-03-30 |
Triple Hair Inc |
Composición que comprende resveratrol y melatonina para reducir la caída y/o aumentar el crecimiento del cabello
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
GB201604484D0
(en)
|
2016-03-16 |
2016-04-27 |
Antibiotx Aps And Københavns Uni University Of Copenhagen |
Topical antibacterial compositions
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
KR20180126582A
(ko)
|
2016-04-01 |
2018-11-27 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
스테로이드 호르몬 약제학적 조성물
|
US10549129B2
(en)
|
2016-06-24 |
2020-02-04 |
The Procter & Gamble Company |
Cosmetic compositions and methods providing enhanced penetration of skin care actives
|
MX2020012139A
(es)
|
2016-09-08 |
2021-01-29 |
Vyne Pharmaceuticals Inc |
Composiciones y metodos para tratar rosacea y acne.
|
KR102499141B1
(ko)
|
2016-10-31 |
2023-02-13 |
신신제약 주식회사 |
수면장애 치료용 경피흡수제제
|
WO2018118197A1
(en)
*
|
2016-12-21 |
2018-06-28 |
Richard Postrel |
Healthier aging in domesticated animals
|
WO2018119400A1
(en)
|
2016-12-22 |
2018-06-28 |
Profusa, Inc. |
System and single-channel luminescent sensor for and method of determining analyte value
|
EP3565617A1
(de)
|
2017-01-06 |
2019-11-13 |
Chrono Therapeutics Inc. |
Vorrichtungen und verfahren zur transdermalen wirkstofffreisetzung
|
US10396053B2
(en)
*
|
2017-11-17 |
2019-08-27 |
General Electric Company |
Semiconductor logic device and system and method of embedded packaging of same
|
US11523994B2
(en)
|
2018-01-10 |
2022-12-13 |
Celista Pharmaceuticals Llc |
Testosterone transdermal spray with film
|
AU2019279884A1
(en)
|
2018-05-29 |
2020-12-10 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
WO2020006322A1
(en)
|
2018-06-27 |
2020-01-02 |
CoLabs International Corporation |
Compositions comprising silicon dioxide-based particles including one or more agents
|
AU2019381810A1
(en)
*
|
2018-11-16 |
2021-06-03 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|
CN114007617A
(zh)
*
|
2019-05-31 |
2022-02-01 |
葡瑞慕生物技术有限公司 |
用于经黏膜给药药物活性成分的单位剂型
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
KR102503159B1
(ko)
|
2020-04-29 |
2023-02-23 |
신신제약 주식회사 |
멜라토닌을 함유하는 경피흡수제제
|
US11977085B1
(en)
|
2023-09-05 |
2024-05-07 |
Elan Ehrlich |
Date rape drug detection device and method of using same
|